FMP
co.don AG
CNW.DE
XETRA
Inactive Equity
co.don AG, a biopharmaceutical company, develops, produces, and markets cell-based pharmaceutical products for joint preservation and the regenerative treatment of articular cartilage defects worldwide. It offers Spherox, a three dimensional chondrocyte product that is used to treat cartilage defects in adult knee joints; and co.don chondrosphere for the treatment of cartilage defects in the hip, ankle, shoulder and elbow, and knees of younger patients. The company serves accident and orthopedic surgeons. co.don AG was founded in 1993 and is headquartered in Teltow, Germany.
0.245 EUR
0 (0%)
About
ceo
Dr. Xing Zhao
sector
Healthcare
industry
Biotechnology
website
https://www.codon.de
exchange
XETRA
Description
co.don AG, a biopharmaceutical company, develops, produces, and markets cell-based pharmaceutical products for joint preservation and the regenerative treatment of articular cartilage defects worldwide. It offers Spherox, a three dimensional chondrocyte product that is used to treat cartilage defects in adult knee joints; and co.don chondrosphere for the treatment of cartilage defects in the hip, ankle, shoulder and elbow, and knees of younger patients. The company serves accident and orthopedic surgeons. co.don AG was founded in 1993 and is headquartered in Teltow, Germany.
CIK
N/A
ISIN
N/A
CUSIP
N/A
Address
Warthestraße 21
Phone
49 3328 43 46 0
Country
DE
Employee
134
IPO Date
Feb 14, 2001
Key Executives
